Fisher & Paykel HealthcareFRA:FPLB -3.66%91 FCF Margin % is 23.51% as of Mar. 2026, which is 75% above its 10-year median of 13.43. GuruFocus rates FRA:FPLB with a GF Score™ of 91/100 and a GF Value™ of €21.23. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks better than 90.92% on this metric.
The historical rank and industry rank for Fisher & Paykel Healthcare's FCF Margin % or its related term are showing as below:
FRA:FPLB'
s FCF Margin % Range Over the Past 10 Years
Min: 1.69 Med: 13.43 Max: 34.8
Current: 20.29
During the past 13 years, the highest FCF Margin % of Fisher & Paykel Healthcare was 34.80%. The lowest was 1.69%. And the median was 13.43%.
FRA:FPLB's FCF Margin % is ranked better than 90.92% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs FRA:FPLB: 20.29
Fisher & Paykel Healthcare FCF Margin % Related Terms
Fisher & Paykel Healthcare FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FPLB vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (FRA:FPLB) has a FCF Margin % of 23.51% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fisher & Paykel Healthcare and its competitors. This is 75% above median its historical median of 13.43. Over the past decade, Fisher & Paykel Healthcare's FCF Margin % has ranged from 1.69 to 34.80. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #74 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 9.1%.
Is Fisher & Paykel Healthcare's FCF Margin % too high?
Fisher & Paykel Healthcare's current FCF Margin % of 23.51% is 75% above median its 10-year median of 13.43. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 34.80. Based on the distribution chart, Fisher & Paykel Healthcare ranks #74 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fisher & Paykel Healthcare has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #74 out of 815 companies for FCF Margin %. This places Fisher & Paykel Healthcare in the top 9% of its industry — outperforming the majority of peers. Historically, Fisher & Paykel Healthcare's own FCF Margin % has ranged from 1.69 to 34.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current FCF Margin % is 23.51%, which is 75% above median its own 10-year median of 13.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Fisher & Paykel Healthcare (FRA:FPLB) has a current FCF Margin % of 23.51%. The stock's GF Value™ is €21.23, compared to a current price of €18.40 — trading 13.3% below its estimated fair value. The current FCF Margin % is 23.51%, which is 75% above median its 10-year median of 13.43. Fisher & Paykel Healthcare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FRA:FPLB), the current FCF Margin % is 23.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FRA:FPLB) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of €18.40 is trading 13.3% below its estimated GF Value™ of €21.23.
Key valuation signals for FRA:FPLB:
FCF Margin %: 23.51% (75% above median its 10-year median of 13.43)
GF Value™: €21.23 vs. price of €18.40 (13.3% below fair value)
No single metric tells the full story. See the FRA:FPLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
91GF Score
Get the complete analysis for FRA:FPLB
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FPLB has been successfully added to your 
